https://www.premera.com/medicalpolicies/1.01.538.pdf#search=policy
MEDICAL POLICY - 1.01.538 Cooling Devices Used in the Outpatient Setting BCBSA Ref. Policy: 1.01.26 Effective Date: June 1, 2024 Last Revised: May 13, 2024 Replaces: 1.01.26 ...
https://www.premera.com/medicalpolicies/2.01.100.pdf#search=policy
MEDICAL POLICY - 2.01.100 Dry Needling of Trigger Points for Myofascial Pain BCBSA Ref. Policy: 2.01.100 Effective Date: July 1, 2024 Last Revised: June 10, 2024 Replaces: N/A ...
https://www.premera.com/medicalpolicies/2.02.506.pdf#search=policy
MEDICAL POLICY - 2.02.506 Wearable Cardioverter-Defibrillators as a Bridge to Implantable Cardioverter-Defibrillator Placement BCBSA Ref. Policy: 2.02.15, 7.01.44 Effective Date: ...
https://www.premera.com/medicalpolicies/2.04.136.pdf#search=policy
MEDICAL POLICY - 2.04.136 Nutrient/Nutritional Panel Testing BCBSA Ref. Policy: 2.04.136 Effective Date: Mar. 1, 2025 Last Revised: Feb. 10, 2025 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/4.02.06.pdf#search=policy
MEDICAL POLICY - 4.02.06 Uterus Transplantation for Absolute Uterine Factor Infertility BCBSA Ref. Policy: 4.02.06 Effective Date: Nov. 1, 2024 Last Revised: Oct. 7, 2024 ...
https://www.premera.com/medicalpolicies/5.01.42.pdf#search=policy
MEDICAL POLICY - 5.01.42 Gene Therapies for Thalassemia BCBSA Ref. Policy: 5.01.42 Effective Date: May 1, 2025 Last Revised: Apr. 21, 2025 Replaces: N/A RELATED MEDICAL POLICIES: ...
https://www.premera.com/medicalpolicies/5.01.532.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.532 Cutaneous T-Cell Lymphomas (CTCL): Systemic ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.551.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.551 Use of Granulocyte Colony-Stimulating Factors (G-CSF) Effective Date: Mar. 1, 2025* Last Revised: Apr. 15, 2025 Replaces: N/A *This policy has ...
https://www.premera.com/medicalpolicies/5.01.556_2025-07-01.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.556 Rituximab: Non-oncologic and Miscellaneous Uses BCBSA Ref. Policy: 5.01.24 Effective Date: July 1, 2025* Last Revised: Feb. 11, 2025 Replaces: ...
https://www.premera.com/medicalpolicies/5.01.593.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.593 Pharmacologic Treatment of Transthyretin-Mediated Amyloidosis BCBSA Ref. Policy: 5.01.30 Effective Date: May 6, 2025 Last Revised: Mar. 24, ...
https://www.premera.com/medicalpolicies/5.01.608.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.608 Pharmacologic Treatment of Postpartum Depression BCBSA Ref. Policy: 5.01.33 Effective Date: Mar. 1, 2025 Last Revised: Feb. 24, 2025 Replaces: ...
https://www.premera.com/medicalpolicies/5.01.628.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.628 Pharmacologic Treatment of Atopic Dermatitis ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.651.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.651 Pharmacologic Treatment of Parkinson's Disease ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/1.01.24.pdf#search=policy
MEDICAL POLICY - 1.01.24 Interferential Current Stimulation BCBSA Ref. Policy: 1.01.24 Effective Date: Aug. 1, 2024 Last Revised: July 22, 2024 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/1.01.539.pdf#search=policy
MEDICAL POLICY - 1.01.539 Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions BCBSA Ref. Policy: 1.01.15 Effective Date: Nov. 1, 2024 Last ...
https://www.premera.com/medicalpolicies/1.01.540.pdf#search=policy
MEDICAL POLICY - 1.01.540 Continuous Passive Motion in the Home Setting BCBSA Ref. Policy: 1.01.10 Effective Date: June 1, 2024 Last Revised: May 13, 2024 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/2.01.91.pdf#search=policy
MEDICAL POLICY - 2.01.91 Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and Gastroparesis BCBSA Ref. Policy: 2.01.91 Effective Date: Feb. 1, 2025 Last Revised: ...
https://www.premera.com/medicalpolicies/2.02.26.pdf#search=policy
MEDICAL POLICY - 2.02.26 Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation BCBSA Ref. Policy: 2.02.26 Effective Date: August 1, 2024 ...
https://www.premera.com/medicalpolicies/2.02.507.pdf#search=policy
MEDICAL POLICY - 2.02.507 Coronary Angiography for Known or Suspected Coronary Artery ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/2.04.513.pdf#search=policy
MEDICAL POLICY - 2.04.513 Drug Testing in Pain Management and Substance Use Disorder Treatment Settings BCBSA Ref. Policy: 2.04.98 Effective Date: Feb. 1, 2025 Last Revised: Jan. ...